Results 151 to 160 of about 23,761 (257)

The use of diabetes technology under aviation conditions: A systematic review of human and in‐vitro studies and future considerations

Diabetic Medicine, Volume 43, Issue 4, April 2026.
Abstract Background Despite advancements in diabetes management technologies, restrictions on insulin‐treated pilots persist, underscoring the need to evaluate the safety, efficacy and performance of these technologies in aviation settings. This systematic review aims to summarize the available evidence on the performance, safety and effectiveness of ...
Renald Meçani, Taulant Muka, Monika Cigler, Silvia Basta, Omaima El‐Hakouni, Petra M. Baumann, David Sanchez, Mikkel Thor Olsen, Chantal Mathieu, Thomas R. Pieber, Gerd Koehler, Julia K. Mader   +11 more
wiley   +1 more source

Dual action of imeglimin on insulin secretion and sensitivity in type 2 diabetes

Diabetes, Obesity and Metabolism, Volume 28, Issue 4, Page 2744-2756, April 2026.
Abstract Aims Imeglimin is a novel oral hypoglycemic agent approved for the treatment of type 2 diabetes in Japan, with dual actions to enhance insulin secretion and improve insulin sensitivity, suggested by preclinical evidence. However, the effect of imeglimin on tissue‐specific insulin sensitivity and glucose kinetics using glucose tracers is ...
Tsubasa Tajima, Hideyoshi Kaga, Naoaki Ito, Toshiki Kogai, Hitoshi Naito, Saori Kakehi, Satoshi Kadowaki, Yuya Nishida, Ryuzo Kawamori, Yoshifumi Tamura, Hirotaka Watada   +10 more
wiley   +1 more source

International clinical opinion on transparency, standardisation, and calibration alignment in the performance evaluation of systems for continuous glucose monitoring

Diabetes, Obesity and Metabolism, Volume 28, Issue 4, Page 2551-2565, April 2026.
Abstract Continuous glucose monitoring (CGM) is now central to diabetes management, yet variation in how respective medical products are evaluated limits meaningful comparison between CGM systems. Three barriers currently constrain reliable interpretation of glucose‐derived measures.
John S. Pemberton, Robert C. Andrews, Katharine Barnard‐Kelly, Tadej Battelino, Thomas Danne, Lutz Heinemann, Partha Kar, Alistair Lumb, David M. Maahs, Julia K. Mader, Chantal Mathieu, Viswanathan Mohan, Helen R. Murphy, Eleanor M. Scott, Jennifer L. Sherr, Carmel E. Smart, Martin Tauschmann, Amanda Williams, Emma G. Wilmot, Dessi P. Zaharieva, Othmar Moser   +20 more
wiley   +1 more source

Association between daily steps, diabetes management and health indicators in people living with type 1 diabetes: A cross‐sectional study from the BETTER registry

Diabetes, Obesity and Metabolism, Volume 28, Issue 4, Page 2908-2918, April 2026.
Abstract Aims In people with type 1 diabetes, physical activity provides important health benefits but is mainly limited by fear of hypoglycaemia. Daily step count is a simple indicator of ambulatory activity. This study examined associations between step count and health indicators.
Thélo I. Garré, Capucine G. Guédet, Laure Alexandre‐Heymann, Virginie Messier, Valérie Boudreau, Semah Tagougui, Claude Laforest, Anne‐Sophie Brazeau, Rémi Rabasa‐Lhoret, Jane E. Yardley   +9 more
wiley   +1 more source

Comparison of pharmacodynamics and pharmacokinetics of ultra‐rapid‐acting insulin aspart and rapid‐acting insulin aspart around continuous moderate intensity exercise in adults with type 1 diabetes: A randomised controlled trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 4, Page 3002-3010, April 2026.
Abstract Aims To compare the effects of dose reductions of ultra‐rapid‐acting insulin aspart (URA‐IAsp) and rapid‐acting insulin aspart (IAsp) on blood glucose concentrations during continuous moderate‐intensity exercise in people with type 1 diabetes (T1D).
Jason P. Pitt, Alexander Müller, Chloe Nicholas, Olivia M. McCarthy, Othmar Moser, Stephen C. Bain, Harald Sourij, Richard M. Bracken   +7 more
wiley   +1 more source

Theragnostic utility of continuous glucose monitoring in post‐gastrectomy hypoglycemia

Journal of Diabetes Investigation
Diagnosing post‐gastrectomy hypoglycemia is challenging, often relying on medical history with documented low plasma glucose levels. Here, we present three cases of patients who presented a high probability of post‐gastrectomy hypoglycemia diagnosed and ...
Heejun Son, Bon Hyang Lee, Young Min Cho
doaj   +1 more source

Postprandial reactive hypoglycemia detected with premature ventricular contraction

QJM: An International Journal of Medicine, 2022
H Honda, S Tanaka, H Hagiya, F Otsuka
openaire   +2 more sources

Safety of anagliptin/metformin combination tablets evaluated by non‐inferiority between pre‐ and post‐serum lactic acid levels in Japanese patients with type 2 diabetes and moderate renal impairment (AMELIO STUDY)

Journal of Diabetes Investigation, Volume 17, Issue 4, Page 636-648, April 2026.
To investigate the safety of anagliptin/metformin combination tablets in Japanese patients of type 2 diabetes with moderate renal impairment. This study demonstrates that the fixed‐dose combination of anagliptin and metformin can be used safely in patients with type 2 diabetes complicated by moderate renal dysfunction.
Hiroshi Kajio, Ryotaro Bouchi, Mitsuhisa Komatsu, Masanori Yamazaki, Daisuke Takarabe, Masahide Okamoto, Takahisa Tanaka, Toru Kitazawa, Hisayuki Katsuyama, Yasumichi Mori, Mitsuhiko Noda   +10 more
wiley   +1 more source

Does tight control of blood glucose in pregnant women with diabetes improve neonatal outcomes? [PDF]

, 2004
In pregnant women with preexisting type 1 diabetes mellitus, maintaining near-normal blood glucose levels decreases the rate of major congenital anomalies (defined as those causing death or a serious handicap necessitating surgical correction or medical ...
Dodson, Sherry, Fotinos, Charissa
core  

Effects of switching from MiniMed™ 770G to 780G on continuous glucose monitoring metrics and DTR‐QOL scores: An observational study of Japanese people with type 1 diabetes mellitus

Journal of Diabetes Investigation, Volume 17, Issue 4, Page 681-688, April 2026.
Glycemic outcomes following continuous glucose monitoring. The switch date from the MiniMed™ 770G to the 780G was defined as Week 0, and data were extracted at 2 weeks before the switch (Week −2), as well as at Week 0, Week 12, Week 24, Week 36, and Week 48.
Eri Takagi, Junko Sato, Tatsuhiro Ayame, Shohei Fujikawa, Ryoki Mori, Haruna Yasuda, Azusa Ozaki, Haruki Nagashima, Mami Koshibu, Yuya Nishida, Fuki Ikeda, Hirotaka Watada   +11 more
wiley   +1 more source